SEARCH

SEARCH BY CITATION

References

  • 1
    Jones RH, Lydeard SE, Hobbs FDR, et al. Dyspepsia in England and Scotland. Gut 1990; 31: 401 5.
  • 2
    Jones R & Lydeard S. Prevalence of symptoms of dyspepsia in the community. Lancet 1989; 1: 47 51.
  • 3
    Gear MWL & Barnes RJ. Endoscopic studies of dyspepsia in general practice. Br Med J 1989; 1: 1136 7.
  • 4
    Jones R. Upper gastrointestinal endoscopy—a view from general practice. R Coll Gen Pract 1986; 36: 6 8.
  • 5
    Williams B, Luckas M, Ellingham JHM, et al. Do young patients with dyspepsia need investigation? Lancet 1988; 11: 1349 51.
  • 6
    Cheshire M. Patient outcomes, a new agenda. Clinician in management. 1995; 4(5).
  • 7
    NHS Executive. Promoting clinical effectiveness: A framework for action in and throughout the NHS. Crown Copyright 1996.
  • 8
    Felton A & Lister G. Consider the Evidence, The NHS on the Move Towards Evidence Based Medicine. Uxbridge: Coopers and Lybrand, 1996.
  • 9
    Forrester E. Alternative advice on dyspepsia treatment. Gasto-renterol Pract 1994; Feb/Mar: 6–7.
  • 10
    Heatley R. Dyspepsia: GP guide to drug management. Prescriber 1995; 19 October: 39 50.
  • 11
    Crompton B. Dyspepsia: A rational approach to management. Prescriber 1995; 19 October: 52 56.
  • 12
    Bytzer P, Hansen JM, Schaffalitzky de Mauckadell OB. Empirical H2-blocker therapy or prompt endoscopy management of dyspepsia . Lancet 1994; 343: 811 16.
  • 13
    Thompson G. Dyspepsia: Is a trial of therapy appropriate? Can Med Assoc J 1995; 153: 293 329.
  • 14
    Mucklow JC, Haycox AR, Wood KMG, Jones PW, Green JRB. Cost-effective management of dyspepsia. Br J Med Econ 1996; 10: 119 27.
  • 15
    British Society of Gastroenterology. Guidelines in Gastroenterology 1; Dyspepsia Management Guidelines. September 1996.
  • 16
    Venables T, Newland R, Patel AC, et al. A comparison of omeprazole 10 mg and 20 mg o.m. with ranitidine 150 mg b.d. for the treatment of GORD in primary care. Gut 1995; 37(Suppl. 12): A45(Abstract F177).
  • 17
    Bate CM, Booth SN, Crowe JP, et al. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Gut 1995; 36: 492 8.
  • 18
    Robinson M, Maton PN, Allan ML, et al. The effect of different doses of omeprazole on 24 hour oesophageal acid exposure in patients with gastroesophageal reflux. Aliment Pharmacol Ther 1991; 5: 645 61.
  • 19
    Goves J, Oldring JK, Kerr D, et al.First line treatment with omeprazole 10 mg om is a more effective strategy than Gaviscon 10 mL qid in the relief of dyspepsia symptoms in primary care. Gut 1996; 39(Suppl. 1): A40(Abstract T157).
  • 20
    Manning AP, Thompson WG, Heaton KW, et al. Towards diagnosis of the irritable bowel. Br Med J 1978; 2: 653 4.